Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Robert

Showing results (971-980 of 1,037) with videos related to

Pageof 104
Sort By:
The American Journal of Psychiatry|June 3, 2010
The Internet-based MGS2 control sample: self report of mental illnessAlan R Sanders, Douglas F Levinson, Jubao Duan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2021
Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006G V Long, A Arance, L Mortier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC studyD Schadendorf, M M Amonkar, M Milhem, et al.
The Lancet. Global Health|July 25, 2025
Clinical impact and cost-effectiveness of the WHO-recommended advanced HIV disease package of careEmily P Hyle, Thulani Maphosa, Ajay Rangaraj, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 9, 2016
The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group studyC M C Oude Ophuis, C Verhoef, P Rutkowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001O Hamid, C Robert, A Daud, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2006
The complete genome sequence of Lactobacillus bulgaricus reveals extensive and ongoing reductive evolutionM van de Guchte, S Penaud, C Grimaldi, et al.
Chest|February 5, 2025
Trajectories of Interferon-Gamma Release Assay Results Over 2 Years in Independent Cohorts From China, South Africa, Tanzania, and the United StatesCheng Chen, Hao Xue, C Robert Horsburgh, et al.
The Lancet. Global Health|January 27, 2019
Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling studyKrishna P Reddy, Ankur Gupta-Wright, Katherine L Fielding, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2004
Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of functionErik G Puffenberger, Diane Hu-Lince, Jennifer M Parod, et al.
Pageof 104

Showing results (971-980 of 1,037) with videos related to

Sort By:
Pageof 104
The American Journal of Psychiatry|June 3, 2010
The Internet-based MGS2 control sample: self report of mental illnessAlan R Sanders, Douglas F Levinson, Jubao Duan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2021
Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006G V Long, A Arance, L Mortier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC studyD Schadendorf, M M Amonkar, M Milhem, et al.
The Lancet. Global Health|July 25, 2025
Clinical impact and cost-effectiveness of the WHO-recommended advanced HIV disease package of careEmily P Hyle, Thulani Maphosa, Ajay Rangaraj, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 9, 2016
The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group studyC M C Oude Ophuis, C Verhoef, P Rutkowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001O Hamid, C Robert, A Daud, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2006
The complete genome sequence of Lactobacillus bulgaricus reveals extensive and ongoing reductive evolutionM van de Guchte, S Penaud, C Grimaldi, et al.
Chest|February 5, 2025
Trajectories of Interferon-Gamma Release Assay Results Over 2 Years in Independent Cohorts From China, South Africa, Tanzania, and the United StatesCheng Chen, Hao Xue, C Robert Horsburgh, et al.
The Lancet. Global Health|January 27, 2019
Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling studyKrishna P Reddy, Ankur Gupta-Wright, Katherine L Fielding, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2004
Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of functionErik G Puffenberger, Diane Hu-Lince, Jennifer M Parod, et al.
Pageof 104